The through-line this issue is who is writing the checks: sovereign-scale capital and state mandates, not product demos. China's BCI sector has already outraised all of 2025, a Shenzhen humanoid firm closed $735M, Rosatom's $13B Bangladesh plant is months from startup, and China caught an orbital booster in a net at sea — while the sharpest US moves are federal deadlines and moonshot money. Deep tech is being funded like industrial policy.

BCI.INTEL · Brain-Computer Interfaces

China's brain-computer interface sector booked 7.25 billion yuan across 64 deals in the first half of 2026 — already past its full-year 2025 total. The figure, from IT Juzi data cited by 36Kr, lands alongside two technical markers: Neuralink's July 1 transdural electrode technique that skips a conventional dura incision, and Meta's Brain2Qwerty v2 decoding model. What moved is the financing base, not a single device — a national capital pool at this depth is the precondition for a BCI industry, and it is concentrating faster than the milestones it is chasing.

Read the full analysis on BCI.INTEL →

HUMANOID.INTEL · Humanoid Robotics

Shenzhen's AI² Robotics closed roughly $735 million at a $2.8 billion valuation, making it one of the most heavily capitalized humanoid-adjacent companies in China. The round pulls from a deliberately broad coalition — the state-backed National SME Development Fund, corporates from Sino Biopharmaceutical to the Moutai Group, and financiers including CICC Capital and GSR Ventures. The bet is architectural: wheeled rather than bipedal, prioritizing industrial deployment over locomotion research. Capital is now picking a form factor, wagering that mobility-plus-manipulation on wheels reaches paying floors before bipeds clear reliability.

Read the full analysis on HUMANOID.INTEL →

QUANTUM.INTEL · Quantum Computing

The Pentagon set a hard 2030 deadline for quantum-resistant encryption across every DoD system, with full employment required by end of 2031. The 25-page post-quantum cryptography strategy, published in June 2026, commits to writing quantum-resistant requirements into the Cybersecurity Maturity Model Certification framework — pulling contractors, not just the department, into scope. Attorneys warn the defense industrial base is nowhere near ready. The significance is procedural: PQC moves from advisory guidance to a procurement gate, and the deadline, not the underlying physics, is what forces a supply chain to migrate.

Read the full analysis on QUANTUM.INTEL →

SMR.INTEL · Small Modular Reactors

Rosatom's $13 billion, 2.4 GW Rooppur plant will supply up to 15% of Bangladesh's electricity, with Unit 1 commissioning targeted for early 2027. The two Russian-built reactors on the Padma River — Unit 2 following in 2028 — were conceived to cut Bangladesh's dependence on imported fossil fuels, and have since become a case study in first-of-a-kind financing risk. The item to watch is the export model: Rosatom ships baseload capacity and long-term geopolitical dependency in the same contract, a template it is repeating across emerging economies.

Read the full analysis on SMR.INTEL →

SYNBIO.INTEL · Synthetic Biology

ARPA-H committed up to $160 million to seven teams to push custom gene-editing therapies into clinical trials. The THRIVE program, announced July 9, runs five years, though at least some teams are expected to reach trial enrollment inside three; each targets a different group of rare diseases across distinct organ systems. Why it matters: federal money is underwriting the economics of ultra-rare, sometimes single-patient edits that no commercial pipeline would fund on its own — the agency is buying down the regulatory and manufacturing path, not just the science.

Read the full analysis on SYNBIO.INTEL →

ORBITAL.INTEL · Space Economy

China's CASC caught a Long March 10B first stage in a net at sea — its first recovery of an orbital-class booster. The 63.6-meter stage lifted from the Wenchang launch site on July 11 and was captured roughly ten minutes later in a tensioned cable net mounted to an offshore vessel — a third reuse architecture, distinct from SpaceX's propulsive drone-ship landings and its Starship tower catch. A working recovery path, however early, puts China on the reusability cost curve that has defined US launch economics: the capability, not just the stated ambition, now exists outside SpaceX.

Read the full analysis on ORBITAL.INTEL →

Also moving: Mitsubishi Motors signed an MOU with startup Highlanders to deploy — and potentially build — humanoids at its Kyoto plant by early 2027 · Scribe Therapeutics filed for a Nasdaq IPO, backed by $120M raised and deals with Biogen, Sanofi, and Eli Lilly · Meitner Energy plans a $1.2B, 300 MW SMR at Argentina's Atucha site · Reflect Orbital secured an FCC license for Eärendil-1, an 18-meter space mirror and the first of a planned 50,000-craft constellation

That's the issue. If a sector moved and we missed it, reply and tell us — a real person reads every response.

Know someone who follows one of these six fields and ignores the other five? Forward this to them.

The Deep Tech Dispatch is published by DeepTech.Intel. Subscribe · deeptechintel.ai